MLchartDataset catalogue

Welireg

Term · Oncology and biomedicine · MLC-T-ONC-009351

A drug used to treat adults with renal cell carcinoma (a type of kidney cancer) that is advanced and adults with certain cancers linked to von Hippel-Lindau disease that do not need surgery right away, including renal cell carcinoma, central nervous system hemangioblastoma (a type of blood vessel tumor), and pancreatic neuroendocrine tumor. It is also being studied in the treatment of other types of cancer. Welireg blocks a certain protein, which may help keep tumor cells from growing and may kill them. It may also prevent the growth of new blood vessels that tumors need to grow. Also called belzutifan.

Table 1. Record
IdentifierMLC-T-ONC-009351
FieldOncology and biomedicine
Synonymsbelzutifan
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-009351",
  "term": "Welireg",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat adults with renal cell carcinoma (a type of kidney cancer) that is advanced and adults with certain cancers linked to von Hippel-Lindau disease that do not need surgery right away, including renal cell carcinoma, central nervous system hemangioblastoma (a type of blood vessel tumor), and pancreatic neuroendocrine tumor. It is also being studied in the treatment of other types of cancer. Welireg blocks a certain protein, which may help keep tumor cells from growing and may kill them. It may also prevent the growth of new blood vessels that tumors need to grow. Also called belzutifan.",
  "synonyms": [
    "belzutifan"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/welireg/"
}

Record 17,398 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.